|
Harry A. (Hal) Korman serves Mylan as President North America. He oversees the growth and development of Mylan Pharmaceuticals Inc. (MPI) Mylan’s generics business in the United States; Genpharm Inc. the former Canadian subsidiary of Merck Generics and fourth largest generics company in Canada; and UDL Laboratories Inc. the U.S. leader in unit dose packaging. | 